3Friedman AN, Bostom AG, Selhub J, et al. The kidney and homocys- teine metabolism [ J ]. J Am Soc Nephro1,2001,12 ( 3 ) : 2181-2189.
4Akdag I, Yilmaz Y, Kahvecioglu S, et al. Clinical value of the malnutri- tion-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study : a 5-year prospective study [ J ]. Nephron Clin Pract ,2008,1 ( 3 ) : c99-c105.
5Rodriquez-hurbe B, Correa-Rotter R. Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal dis- ease [ J ]. Expert Opin Pharmacother,2010, 11 ( 16 ) : 2687-2698.
6Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the riskof cardiovascular diseases[ J]. N Engl J Med ,2001, 345(18) :1291-1297.
7Zyga S, Christopoulou G, Malliarou M. Malnutrition-inflammation-ather- osclerosis syndrome in patients with end-stage renal disease [ J ]. J Ren Care,2011,37( 1 ) :12-15.